Best VCs for Medical Devices

Partner

Khosla Ventures

Alex invests where computation, biology, and healthcare converge. His scientific and clinical background supports a systems view of biomarker discovery, therapeutics, diagnostics, personalized medicin

Investor

BoxGroup

Arielle invests within BoxGroup's broad earliest-stage mandate. Her differentiated documented context is technical and translational: Harvard bioengineering research, founding a postpartum medical-dev

Partner Emeritus

Big Pi Ventures

Aristos' historical investment lens combines strong technology, team, and market position with realistic commercialization targets. He favors research-based ventures that can bridge academia and indus

General Partner

S3 Ventures

Eric Engineer is part of S3 Ventures's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Lead Seed, Series A, and Series B rounds in bu

General Partner

S3 Ventures

Aaron Perman is part of S3 Ventures's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Lead Seed, Series A, and Series B rounds in bus

Principal

S3 Ventures

Joe Curry is part of S3 Ventures's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Lead Seed, Series A, and Series B rounds in busine

Vice President

S3 Ventures

Nicole Bentz is part of S3 Ventures's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Lead Seed, Series A, and Series B rounds in bus

Associate

S3 Ventures

Anthony Marfisi is part of S3 Ventures's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Lead Seed, Series A, and Series B rounds in

Associate

S3 Ventures

Kevin Haley is part of S3 Ventures's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Lead Seed, Series A, and Series B rounds in busi

Senior Associate

S3 Ventures

Will Omberg is part of S3 Ventures's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Lead Seed, Series A, and Series B rounds in busi

Director of Platform & Network

S3 Ventures

Kathryn Deebel is part of S3 Ventures's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Lead Seed, Series A, and Series B rounds in b

Controller

S3 Ventures

Shelley Graves is part of S3 Ventures's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Lead Seed, Series A, and Series B rounds in b

General Partner

Boomerang Ventures

Alex Shandiz invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and pa

Venture Partner

Boomerang Ventures

Ariel MacTavish invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and

Partner and Chief Innovation Officer

Boomerang Ventures

Audrey Beckman invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and

Studio Director

Boomerang Ventures

Dick Aderman is listed in a Studio Director capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and

Founder and Managing Partner

Boomerang Ventures

Oscar Moralez invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and p

Controller and HR Lead

Boomerang Ventures

Todd R. Lugar is listed in a Controller and HR Lead capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinc

Partner and Chief Financial Officer

Boomerang Ventures

Tony Petrucciani is listed in a Partner and Chief Financial Officer capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves t

Co-Founder and Partner

Mutual Capital Partners

Bill Trainor invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have st

Co-Founder and Partner

Mutual Capital Partners

Wayne Wallace invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have s

Project Leader

Boomerang Ventures

Ally Thill is listed in a Project Leader capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and us

Venture Partner

Boomerang Ventures

Dan Clark invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patie

Partner

Boomerang Ventures

David Helmer invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and pa

Partner and Chief Medical Officer

Boomerang Ventures

Eric Beier invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and pati

Associate

Boomerang Ventures

Tejas Vijh invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and pati

Principal

Mutual Capital Partners

Liz Todia Zambory invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that ha

Senior Associate

Mutual Capital Partners

Will Brune invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have stro

President and Chief Executive Officer

The Launch Place

At the firm level, The Launch Place provides catalytic pre-seed and seed capital plus consulting to scalable technology companies willing to build operations in the Dan River region.

Vice President

The Launch Place

At the firm level, The Launch Place provides catalytic pre-seed and seed capital plus consulting to scalable technology companies willing to build operations in the Dan River region.

Office Manager

The Launch Place

At the firm level, The Launch Place provides catalytic pre-seed and seed capital plus consulting to scalable technology companies willing to build operations in the Dan River region.

Founding Partner

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Founding Member

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Partner

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Chief Scientific Officer

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Managing Partner, GPG Ventures - Houston

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Principal, Investment Operations

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Investment Partner

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Head of Investor Relations

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Managing Partner

RC Capital

Daniel Fleming contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and health

Managing Partner

RC Capital

J. Carter McNabb contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and heal

Managing Partner

RC Capital

Robert Heimann contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and health

Managing Partner

RC Capital

Rurik “Rik” Vandevenne contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services an

Partner

RC Capital

Patrick Dunnigan contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and heal

CFO

RC Capital

Adrienne Vannarsdall contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and

Principal

RC Capital

Parag Rathi contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcar

Principal

RC Capital

Vitaly Goldfeder contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and heal

Principal, Investor Relations & Operations

RC Capital

Britney Hamberg contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healt

Controller

RC Capital

Dana Tanenbaum contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and health

Vice President

RC Capital

Paul Axelrod contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthca

Vice President

RC Capital

Scott Steever contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthc

Vice President

RC Capital

Ryan Moeller contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthca

Senior Associate

RC Capital

Marcus Fields contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthc

Analyst, Investor Relations

RC Capital

Saloni Rai contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare

Analyst, Investments

RC Capital

Kushal Modi contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcar

Analyst, Finance

RC Capital

Britney Byrd contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthca

Manager of Administration

RC Capital

Kaity Lynch contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcar

Managing Partner

Clarevia

Jim Adox invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and devi

Partner

Clarevia

Scott Button invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and

Partner

Clarevia

Paul Weiss invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and de

Partner and Chief Financial Officer

Clarevia

David Arnstein is listed in a Partner and Chief Financial Officer capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared c

Partner

Clarevia

John Neis invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and dev

Chief Medical and Scientific Officer

Clarevia

Joe Amaral, MD is listed in a Chief Medical and Scientific Officer capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared

Principal

Clarevia

Jenni Le invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and devi

Venture Partner

Clarevia

Margaret Kaczor Andrew invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therap

Executive in Residence

Clarevia

Cheryl R. Blanchard, PhD invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from ther

Venture Partner

Clarevia

Shelly Lanning invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic an

Controller

Clarevia

Becky Hoerman is listed in a Controller capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Office Manager

Clarevia

Linda Olson is listed in a Office Manager capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Managing Director

S3 Ventures

Brian R. Smith is part of S3 Ventures's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Lead Seed, Series A, and Series B rounds in b

Managing Director

S3 Ventures

Charlie Plauche is part of S3 Ventures's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Lead Seed, Series A, and Series B rounds in

Partner

Khosla Ventures

Jun backs long-horizon technologies at the intersection of biology, healthcare and frontier engineering. His medical training, decade of bench and clinical research, digital-health operating work and